Axon Therapy
Axon Therapy for Chronic Pain
This revolutionary, non-invasive treatment, for post-traumatic peripheral chronic nerve pain and Diabetic Neuropathy, is now available at ActiveMed Integrative Health Center in Encinitas.
The therapy is comprised of non-invasive gentle magnetic pulses, which penetrate skin and muscle to modulate nerves in the area of pain, turning on the bodies natural pain relieving pathways to provide extended relief.
How Does Axon Therapy Work?
What Conditions Does Axon Therapy Treat?
Peripheral traumatic nerve injury with a history of associated pain for more than 3 months and Diabetic Neuropathy.
Schedule Your Visit Today!
Early clinical evidence from a randomized trial indicates that Axon therapy can reduce chronic nerve pain by more than 44.9% in patients that are refractory to medications. Successive monthly maintenance treatments have shown to further decrease pain relief back to initial levels. As a non-invasive therapy, Axon may lack some of the side-effects associated with current treatment options for chronic nerve pain.
How many treatments does it take for axon therapy to provide me with relief?
It depends on the nature of your chronic pain. For some it just takes one treatment but for others it takes several more. It also depends how long you have had the problem. Although, many people who have had extreme pain diseases for many years have received relief within just a few treatments.
Does Axon Therapy have side effects?
Potential side effects of the magnetic treatment are mild soreness or numbness, resulting from muscle stimulation. Occasionally, skin irritation, like redness and/or pain can occur. This will be assessed by a qualified physician and treated with ointment
Does Axon Therapy Hurt?
No. Some patients describe the small electrical stimulations feeling like the gentle snapping of a rubber band.
How Long Does Axon Therapy Take?
14 minutes per site.
How Often Do I have Axon Therapy Treatments?
- 3 consecutive days week 1.
- Weekly treatments weeks 2-5.
- Bi-monthly treatments month 2.
- Monthly treatments months 3-4.
- Treatments every 3 months as needed for maintenance.
Schedule Your Visit Today!
What Patients are Eligible for axon Therapy?
- A clear diagnosis of traumatic nerve injury.
- History of nerve pain of more than 3 months.
- Average daily nerve pain >3 (0-10 scale).
- Able to attend required visits for treatment protocol (3x week 1, 1x/week weeks 2-4)
- Patients with Diabetic Neuropathy
What Criteria Excludes A Patient For Axon Therapy?
- Pregnancy
- Pacemaker or similar modulatory device implant.
- Ferromagnetic material (e.g. bullet fragment, shrapnel, device implant) in the brain or body close to the site of injury.
- History of dementia, major psychiatric diseases, or life threatening diseases.
- History of seizure.
- Pending litigation.
- History of dementia, major psychiatric diseases, or life threatening diseases.
- Lack of ability to understand the treatment protocol and to adequately communicate in English.
Is Axon Therapy Published?
Transcutaneous Magnetic Stimulation (tMS) in Alleviating Post-Traumatic Peripheral Neuropathic Pain States: A Case Series
Effect of Low Frequency Transcutaneous Magnetic Stimulation on Sensory and Motor Transmission
Schedule Your Visit Today!
Can I talk to someone for more information or schedule an appointment?
Please call 858-673-4400 option 2 to talk to our Axon Therapy clinical specialist.
What other health care services do you provide at activemed for your patients?
We use a combination of acupuncture, herbal medicine, electrical stimulation, diet therapy, structural balancing, exercise therapy, lifestyle counseling, tui na, reflexology, nutraceutical supplementation and other modalities that work to provide safe yet extremely effective health care results. Our main focus is to provide our patients with the right type of health care to suit their individual needs, thereby providing them with the best possible care.
Schedule Your Visit Today!
Axon Therapy: A Breakthrough for Chronic Painful Diabetic Neuropathy
Axon Therapy by Neuralace Medical, Inc. has received FDA clearance for treating Chronic Painful Diabetic Neuropathy (PDN), offering hope to millions. Here’s why it’s groundbreaking:
Non-Invasive Treatment
– Utilizes Magnetic Peripheral Nerve Stimulation (mPNS).
– Painless sessions lasting only 13.5 minutes.
Efficacy and Results
– Double-blind study: 72.3% responder rate at Day 30.
– Significant reductions in pain, numbness, and improvement in quality of life.
– Day 90 results show continued efficacy.
Patient-Centered Care
– CEO Keith Warner emphasizes patient well-being.
– Non-pharmacological, non-invasive option reducing medication dependency.
Future Implications
– Shifts in pain management paradigm.
– Broader access to innovative treatments.
Axon Therapy represents a leap forward in PDN treatment, promising relief and improved quality of life.
FAQs for Axon Therapy
- We use Axon Therapy as a non-invasive magnetic stimulation treatment that delivers focused magnetic pulses to stimulate peripheral nerves to help relieve chronic nerve pain. It’s designed for clinic use (e.g., pain management and physical therapy settings).
- We reference Axon Therapy’s FDA clearance for stimulating peripheral nerves to help relieve chronic intractable pain, post-traumatic pain, post-surgical pain, and chronic painful diabetic peripheral neuropathy (PDN) in the lower extremities, for adults 18+.
- We deliver brief magnetic pulses that induce electrical fields in targeted nerve bundles, aiming to change nerve signaling in ways that reduce neuropathic pain. Published research describes low-frequency mPNS (commonly ~0.5 Hz) as engaging peripheral and central pathways.
- We don’t treat Axon Therapy as the same thing as TENS. mPNS uses magnetic pulses (not adhesive electrodes) and research describes different nerve-fiber recruitment characteristics compared with electrical stimulation approaches like TENS.
- We expect Axon Therapy to be not painful for most people. In clinic descriptions, some patients compare the sensation to a gentle snapping or tapping feeling. Research also describes mPNS as generally well tolerated.
- We typically plan on about 14 minutes per site for Axon Therapy. Device documentation also describes a treatment time window of about 800 seconds (roughly 13–14 minutes) for a standard session.
- We usually follow a front-loaded plan and then taper. One published protocol describes 3 sessions in week 1, then weekly sessions and later reduced frequency; our clinic schedule similarly starts with multiple early visits and then moves to maintenance.
- We may notice changes quickly, but we don’t promise same-day outcomes. Trials follow patients over weeks to months, and some protocols include maintenance treatments to help sustain improvements. We set expectations based on diagnosis, duration, and response over the first few sessions.
- We see strong trial signals in PDN. In a multicenter randomized trial (mPNS + conventional medical management vs sham + conventional medical management), the per-protocol analysis reported a 72.3% responder rate at day 30 and 81.4% at day 90 (responder = ≥50% pain reduction).
- We see favorable outcomes in a randomized multi-site trial (SEAT Study) comparing mPNS + conventional medical management vs conventional medical management alone, reporting 71% responders at 3 months in the mPNS+CMM group versus 13% in CMM alone (responder = >50% pain relief).
- We define “responder” the same way the trials do: we’re typically looking for ≥50% reduction in pain from baseline at a specified time point (e.g., day 30 or day 90), measured with standard pain scales like VAS.
- We usually expect mild, temporary effects—clinic guidance mentions mild soreness or numbness and occasional skin irritation. In the SEAT Study, adverse events occurred in both groups and the paper reports no adverse device effects through day 90.
- We typically consider Axon Therapy when we’re dealing with chronic peripheral nerve pain (often >3 months) and symptoms consistent with traumatic nerve injury or diabetic neuropathy, and when we can commit to the recommended visit cadence.
- We screen out key risk categories—clinic criteria include pregnancy, pacemakers or similar implants, ferromagnetic material near the site, and history of seizure, among other exclusions. We always confirm implants and neurological history before treatment.
- We commonly combine Axon Therapy with broader care instead of treating it like a standalone “magic fix.” Major studies evaluated mPNS alongside conventional medical management (CMM), which reflects real-world practice where we coordinate therapies and monitor outcomes together.